InSitu Biologics, Inc. research brief
CIK 1723443
Generated Nov. 18, 2026, 3:44 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: OAKDALE Minnesota. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Nov. 10, 2026 · D/A · 0001723443-26-000008 · Source evidence
Reported offering amount: 19837423 USD. Reported amount sold: 15037850 USD.
- Oct. 14, 2026 · D/A · 0001723443-26-000006 · Source evidence
Reported offering amount: 3375000 USD. Reported amount sold: 1250000 USD.
- Aug. 10, 2026 · D · 0001723443-26-000005 · Source evidence
Reported offering amount: 2500000 USD. Reported amount sold: 1250000 USD.
- Dec. 18, 2025 · D · 0001723443-25-000003 · Source evidence
Reported offering amount: 8000000 USD. Reported amount sold: 3950000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “InSitu Biologics, Inc. research brief,” CIK 1723443, retrieved Nov. 18, 2026, 3:44 a.m.. Cite the specific accessions used. No amounts have been summed.